Welcome to our dedicated page for Worthington Steel news (Ticker: WS), a resource for investors and traders seeking the latest updates and insights on Worthington Steel stock.
Worthington Steel, Inc. reports company news centered on value-added steel processing, quarterly and annual operating results, dividends, conference calls and corporate updates. Its business updates describe carbon flat-rolled steel processing, electrical steel laminations, tailor welded products and related capabilities such as galvanizing, pickling, configured blanking, specialty cold reduction and lightweighting.
Worthington Steel news also includes disclosures about material agreements, capital-structure matters and shareholder-related developments when they affect the company’s public reporting. The recurring news record reflects a NYSE-listed Ohio company with steel-processing operations across the United States and international markets.
Vicarious Surgical (NYSE: RBOT) announced that Company President Randy Clark will transition to a Board Member role, effective April 25, 2025. As President, Clark led key business functions including product development, operations, clinical regulatory, quality affairs, and human resources.
During his tenure, Clark made significant contributions by:
- Developing manufacturing capabilities and strengthening supply chain
- Establishing key partnerships
- Implementing personnel realignment
- Streamlining business processes
- Formalizing workflows and standardizing procedures
CEO Adam Sachs acknowledged Clark's role in building a strong foundation for future growth. Clark will continue to provide strategic guidance as a Board member, ensuring his expertise remains available to the company while allowing for leadership evolution aligned with strategic and capital needs.
Worthington Steel (NYSE: WS) reported its Q3 fiscal 2025 results, showing significant year-over-year declines. Net sales decreased 15% to $687.4 million from $805.8 million, while operating income fell to $18.3 million from $66.3 million. Net earnings per diluted share dropped to $0.27 from $0.98.
The company's performance was impacted by lower volume and direct selling prices, with direct tons sold decreasing 7% and toll tons down 15%. Gross margin declined by $38.9 million, affected by lower direct spreads and an unfavorable $20.5 million swing in inventory holding positions.
Notable developments include progress on acquiring a controlling stake in Italy-based Sitem Group, receiving Mahle's 2024 Best Supplier award, and declaring a $0.16 quarterly dividend. The company maintains a relatively strong financial position with $63.3 million in cash and $112.2 million in debt.
Worthington Steel (NYSE: WS) has announced its quarterly dividend declaration of $0.16 per common share. The dividend will be paid on June 27, 2025, to shareholders of record as of the close of business on June 13, 2025.
The company also announced it will host a conference call to discuss its fiscal 2025 third quarter results on Thursday, March 20, 2025, at 8:30 a.m. ET. The call will be available via live webcast on the company's Investor Relations website and will remain archived for one year.
Vicarious Surgical (NYSE: RBOT) has reported its Q4 and full year 2024 financial results, marking significant progress with the completion of Version 1.0 System integration. The company expanded strategic partnerships with LSU Health New Orleans, Temple Health, and University of Illinois Health, while preparing for first clinical use in 2025.
Financial highlights for Q4 2024 include operating expenses of $15.0 million (down 3% YoY), with a GAAP net loss of $13.9 million ($2.36 per share). Full year 2024 saw operating expenses of $66.6 million (17% decrease YoY) and a GAAP net loss of $63.2 million ($10.74 per share).
The company ended 2024 with $49.1 million in cash and investments, achieving its 2024 cash burn guidance. For 2025, Vicarious Surgical has set a cash burn guidance of approximately $50 million. The company has appointed Sarah Romano as CFO, effective April 1st, 2025.
Vicarious Surgical (NYSE: RBOT) has appointed Sarah Romano as Chief Financial Officer, effective April 1, 2025. Romano brings decades of financial leadership experience in capital markets, particularly in the healthcare sector. She previously served as CFO of Entero Therapeutics, where she managed financial strategy and executed product in-licensing partnerships.
At her former position as CFO of Kiora Pharmaceuticals, Romano secured over $50 million in funding and led M&A activities. Her expertise includes financial strategy, operations, compliance, budget reviews, forecasting, internal controls oversight, and SEC reporting. Romano holds a Master of Accountancy from Boston College and a B.A. in Accounting from the College of the Holy Cross.
Sky Harbour Group (NYSE American: SKYH), an aviation infrastructure company developing a nationwide network of Home-Basing campuses for business aircraft, has scheduled its Full Year 2024 financial results announcement and Form 10-K filing for March 27, 2025, after market close.
The company will host an investor webcast at 5:00 pm ET the same day, featuring a review of quarterly and annual financial results, a general business update, and a Q&A session with leadership. The webcast will be accessible through the company's investor relations website and will be available for replay after the event.
OppFi (NYSE: OPFI) reported strong financial results for Q4 and full-year 2024, with significant year-over-year growth. Net income surged 112.4% to $83.8 million for full-year 2024, marking the company's tenth consecutive profitable year.
Key highlights include:
- Full-year adjusted net income up 99.2% to $82.7 million
- EPS improved to $0.36 from -$0.06 in 2023
- Adjusted EPS increased 95.5% to $0.95
- Net charge-offs decreased 440 basis points to 39.1%
- Average yield increased 416 basis points to 131.4%
The company provided optimistic guidance for 2025, projecting:
- Revenue growth of 7-13% ($563-594 million)
- Adjusted net income growth of 15-17% ($95-97 million)
- Q1 2025 adjusted net income of $22-24 million
Southland Holdings (NYSE: SLND) reported its Q4 and full-year 2024 financial results, showing significant declines across key metrics. Q4 2024 revenue decreased 15.5% to $267.3 million, with gross profit falling to $7.7 million from $21.1 million year-over-year. The quarterly net loss improved slightly to $4.2 million ($(0.09) per share) compared to $5.6 million loss in Q4 2023.
Full-year 2024 performance showed broader challenges with revenue declining 15.5% to $980.2 million from $1.2 billion in 2023. The company reported a substantial gross loss of $63.0 million, compared to a $35.8 million gross profit in 2023. Net loss widened significantly to $105.4 million ($(2.19) per share) from $19.3 million in 2023. The Materials & Paving business notably impacted results negatively, contributing to $83.1 million in gross losses for the year.
Worthington Steel (NYSE: WS) has scheduled its fiscal third quarter 2025 earnings release and conference call. The company will release its financial results after market close on Wednesday, March 19, 2025. A conference call to discuss the quarterly performance is scheduled for Thursday, March 20, 2025, at 8:30 a.m. ET. Investors can access the live webcast through the Investor Relations section of WorthingtonSteel.com, where it will remain archived for one year.
Vicarious Surgical (NYSE: RBOT) has scheduled its Fourth Quarter and Fiscal Year 2024 financial results announcement for March 17, 2025, after market close. The robotics technology company, focused on advancing robotic surgery, will host a conference call at 4:30 p.m. Eastern Time to discuss the results.
Investors can participate in the conference call by dialing +1 833-470-1428 (domestic) or +1 404-975-4839 (international) with access code 373279. A webcast will be available live and archived at the company's investor relations website.